RBV Capital is a dedicated life sciences venture capital fund established in 2014 with a portfolio of innovative biomedical projects. The fund completed its investment cycle in 2020 and is currently in the divestment stage.
This profile has not yet been verified by the firm. Information may be incomplete or outdated. Claim this profile to take control of your listing.
Location
Russia
Claim this profile to complete your information, set investment criteria, and start receiving curated deal flow from sponsors on DEALITHIC.